Business Context and Reporting Period
Company: Infinite Eagle Acquisition Corp. (IEAG)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2025 (Inception: August 8, 2025)
Business Model: A Cayman Islands exempted company (blank check company/SPAC) formed to effect a merger, share exchange, or asset acquisition with one or more businesses. The Company has no operations and no revenue to date.
Key Subsequent Event: The Company consummated its Initial Public Offering (IPO) on January 20, 2026, and fully exercised the over-allotment option on January 23, 2026. These events occurred after the balance sheet date but are material to the Company's current status.
Key Financial Metrics
As of December 31, 2025 (Pre-IPO Balance Sheet):
- Revenue: $0 (No operations)
- Net Loss: $60,111 (Inception through Dec 31, 2025)
- Cash and Cash Equivalents: $0
- Total Assets: $361,445 (Primarily deferred offering costs of $356,797)
- Total Liabilities: $396,556 (Includes $105,250 promissory note to Sponsor and $291,306 in accounts payable/accrued costs)
- Working Capital Deficit: $286,658
- Shareholder's Deficit: ($35,111)
Post-IPO Capitalization (Subsequent to Dec 31, 2025):
- Gross Proceeds (IPO + Over-Allotment): $345,000,000 ($300M initial + $45M over-allotment)
- Private Placement Proceeds: $3,950,000 ($3.5M initial + $450k over-allotment)
- Funds in Trust Account: $345,000,000 (Invested in U.S. government treasury obligations or money market funds)
- Transaction Costs: $16,016,310 (Includes $3,450,000 underwriting discount and $12,075,000 deferred underwriting fees)
- Available for Business Combination: Approximately $332,925,000 (Net of deferred fees)
Material Changes vs. Prior Period
The reporting period covers the Company's inception through December 31, 2025. There is no prior comparable period as the Company was formed on August 8, 2025. The most significant material change occurred subsequent to the reporting period:
- Capital Raise: Transitioned from a pre-revenue shell with a working capital deficit to a public company with $345 million in trust assets following the January 2026 IPO and over-allotment exercise.
- Debt Repayment: The $105,250 promissory note outstanding to the Sponsor as of Dec 31, 2025, was repaid in full on January 20, 2026.
- Share Structure: Issued 34,500,000 Class A ordinary shares (via Units) and 395,000 Private Placement Shares. 8,625,000 Class B Founder Shares remain outstanding.
Guidance, Outlook, Risks, and Contingencies
Outlook and Timeline: The Company has 24 months from the closing of the IPO (January 20, 2026) to complete an initial business combination. This extends to 30 months if a letter of intent or definitive agreement is executed within the first 24 months. If no combination is completed, the Company will liquidate and redeem public shares.
Management Commentary: Management intends to target businesses with pro forma equity values greater than the net proceeds available. They plan to use the Trust Account funds, equity, debt, or a combination thereof to complete a transaction. The management team has extensive experience in SPACs and strategic investments.
Risks and Contingencies:
- Liquidity Risk: As of Dec 31, 2025, the Company had $0 cash. Post-IPO liquidity is dependent on funds held outside the Trust Account (approx. $50,000 initially) and interest income withdrawn from the Trust (limited to $1,000,000 annually).
- Redemption Risk: Public shareholders may redeem shares for cash upon a business combination. If redemptions exceed available cash, the transaction may fail.
- Trust Account Claims: While the Sponsor has agreed to indemnify the Trust Account against third-party claims (excluding underwriters and waived claims), there is no guarantee the Sponsor has sufficient assets to satisfy such obligations.
- Geopolitical Risks: Ongoing conflicts (Russia-Ukraine, Israel-Hamas) and trade policy changes could adversely affect the search for a target or the target's operations.
- Investment Company Act: The Company must ensure it does not be deemed an "investment company" under the Investment Company Act of 1940, which would impose restrictive regulations.
Important Facts for Investor Verification
- Trust Account Balance: Verify the current balance in the Trust Account ($345,000,000 as of Jan 23, 2026) and the specific investment vehicles (U.S. Treasuries vs. Money Market Funds) to assess interest income potential and safety.
- Completion Deadline: Confirm the exact deadline for the business combination (24 or 30 months from Jan 20, 2026) and any potential extension mechanisms.
- Redemption Thresholds: Review the specific terms regarding the 15% redemption limit for "Excess Shares" if a shareholder vote is required.
- Deferred Underwriting Fees: Note the $12,075,000 deferred fee payable only upon successful completion of a business combination; this reduces the net cash available to the combined entity.
- Sponsor Indemnification: Assess the financial strength of the Sponsor (Eagle Equity Partners VI, LLC) to determine the likelihood of them fulfilling indemnification obligations if third-party claims reduce the Trust Account below $10.00 per share.
- Founder Share Dilution: Understand that Founder Shares convert to Class A shares to maintain a 20% ownership stake post-combination, which may result in significant dilution to public shareholders if additional equity is issued.